Zhang HL - Search Results

1

Significantly upregulated TACSTD2 and Cyclin D1 correlate with poor prognosis of invasive ductal breast cancer.

Lin H, Huang JF, Qiu JR, Zhang HL, Tang XJ, Li H, Wang CJ, Wang ZC, Feng ZQ, Zhu J. Lin H, et al. Among authors: zhang hl. Exp Mol Pathol. 2013 Feb;94(1):73-8. doi: 10.1016/j.yexmp.2012.08.004. Epub 2012 Sep 29. Exp Mol Pathol. 2013. PMID: 23031786

2

Characteristic gene expression profiles in the progression from liver cirrhosis to carcinoma induced by diethylnitrosamine in a rat model.

Liu YF, Zha BS, Zhang HL, Zhu XJ, Li YH, Zhu J, Guan XH, Feng ZQ, Zhang JP. Liu YF, et al. Among authors: zhang jp, zhang hl. J Exp Clin Cancer Res. 2009 Jul 29;28(1):107. doi: 10.1186/1756-9966-28-107. J Exp Clin Cancer Res. 2009. PMID: 19638242 Free PMC article.

3

Potential therapeutic target and independent prognostic marker of TROP2 in laryngeal squamous cell carcinoma.

Wu H, Xu H, Zhang S, Wang X, Zhu H, Zhang H, Zhu J, Huang J. Wu H, et al. Head Neck. 2013 Oct;35(10):1373-8. doi: 10.1002/hed.23138. Epub 2012 Sep 18. Head Neck. 2013. PMID: 22987366

4

Upregulated ZO-1 correlates with favorable survival of gastrointestinal stromal tumor.

Zhu H, Lu J, Wang X, Zhang H, Tang X, Zhu J, Mao Y. Zhu H, et al. Med Oncol. 2013;30(3):631. doi: 10.1007/s12032-013-0631-7. Epub 2013 Jul 3. Med Oncol. 2013. PMID: 23820955

5

The inhibitory effect of a new scFv/tP protein as siRNA delivery system to target hWAPL in cervical carcinoma.

Zhang H, Mao Y, Zhang F, Ye C, Tong H, Su Y, Zhu J. Zhang H, et al. Mol Cell Biochem. 2014 Jun;391(1-2):77-84. doi: 10.1007/s11010-014-1989-3. Epub 2014 Feb 25. Mol Cell Biochem. 2014. PMID: 24567178

6

ROR1 expression correlated with poor clinical outcome in human ovarian cancer.

Zhang H, Qiu J, Ye C, Yang D, Gao L, Su Y, Tang X, Xu N, Zhang D, Xiong L, Mao Y, Li F, Zhu J. Zhang H, et al. Sci Rep. 2014 Jul 24;4:5811. doi: 10.1038/srep05811. Sci Rep. 2014. PMID: 25056203 Free PMC article.

7

High APRIL expression correlates with unfavourable survival of gastrointestinal stromal tumour.

Xian H, Zhang H, Zhu H, Wang X, Tang X, Mao Y, Zhu J. Xian H, et al. Pathology. 2014 Dec;46(7):617-22. doi: 10.1097/PAT.0000000000000162. Pathology. 2014. PMID: 25393252

8

Overexpression of MAGE-A9 predicts unfavorable outcome in breast cancer.

Xu X, Tang X, Lu M, Tang Q, Zhang H, Zhu H, Xu N, Zhang D, Xiong L, Mao Y, Zhu J. Xu X, et al. Exp Mol Pathol. 2014 Dec;97(3):579-84. doi: 10.1016/j.yexmp.2014.11.001. Epub 2014 Nov 5. Exp Mol Pathol. 2014. PMID: 25445503

9

Antitumor activity of a newly developed monoclonal antibody against ROR1 in ovarian cancer cells.

Yin Z, Gao M, Chu S, Su Y, Ye C, Wang Y, Pan Z, Wang Z, Zhang H, Tong H, Zhu J. Yin Z, et al. Oncotarget. 2017 Oct 7;8(55):94210-94222. doi: 10.18632/oncotarget.21618. eCollection 2017 Nov 7. Oncotarget. 2017. PMID: 29212222 Free PMC article.

10

A novel human monoclonal Trop2-IgG antibody inhibits ovarian cancer growth in vitro and in vivo.

Liu J, Yang D, Yin Z, Gao M, Tong H, Su Y, Zhu J, Ye C, Zhang H. Liu J, et al. Biochem Biophys Res Commun. 2019 Apr 30;512(2):276-282. doi: 10.1016/j.bbrc.2019.03.028. Epub 2019 Mar 14. Biochem Biophys Res Commun. 2019. PMID: 30879767

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,081 results

Search Page

Filters